NDC 68083-175-10
Regadenoson .08 mg/mL
Regadenoson · INJECTION, SOLUTION
Regadenoson is an injectable medication given through a vein that works by stimulating adenosine receptors in the body. It is used to help evaluate blood flow to the heart during cardiac stress testing in patients who cannot exercise on a treadmill.
Key Facts
- Brand Name
- Regadenoson
- Generic Name
- Regadenoson
- NDC Code (Package)
68083-175-10- NDC Code (Product)
68083-175- Manufacturer
- Gland Pharma Limited
- Strength
- .08 mg/mL
- Dosage Form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS
- Marketing Status
- Application #
- ANDA207320
- Drug Class
- Adenosine Receptor Agonist [EPC]
- Marketing Start
- 07/12/2022
Recall History
No Recall HistoryView Full Drug Page
Regadenoson — All PackagesNot medical advice. This information is for reference only. Always consult your doctor or pharmacist.